Bronchial Hyperreactivity
"Bronchial Hyperreactivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
Descriptor ID |
D016535
|
MeSH Number(s) |
C08.127.210
|
Concept/Terms |
Bronchial Hyperreactivity- Bronchial Hyperreactivity
- Bronchial Hyperreactivities
- Hyperreactivities, Bronchial
- Hyperreactivity, Bronchial
|
Below are MeSH descriptors whose meaning is more general than "Bronchial Hyperreactivity".
Below are MeSH descriptors whose meaning is more specific than "Bronchial Hyperreactivity".
This graph shows the total number of publications written about "Bronchial Hyperreactivity" by people in this website by year, and whether "Bronchial Hyperreactivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2002 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 1 | 1 | 2 |
2005 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2017 | 2 | 1 | 3 |
2018 | 4 | 1 | 5 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bronchial Hyperreactivity" by people in Profiles.
-
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020]. Rev Mal Respir. 2021 Jan; 38(1):114-121.
-
Clinical utility of ultrahigh fractional exhaled nitric oxide in predicting bronchial hyperresponsiveness in patients with suspected asthma. Postgrad Med J. 2019 Oct; 95(1128):541-546.
-
Protective effects of VGX-1027 in PM2.5-induced airway inflammation and bronchial hyperresponsiveness. Eur J Pharmacol. 2019 Jan 05; 842:373-383.
-
Does lung microbiome play a causal or casual role in asthma? Pediatr Pulmonol. 2018 10; 53(10):1340-1345.
-
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. Respir Res. 2018 04 12; 19(1):65.
-
The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity. Am J Physiol Lung Cell Mol Physiol. 2018 08 01; 315(2):L133-L148.
-
Solitary Cholinergic Stimulation Induces Airway Hyperreactivity and Transcription of Distinct Pro-inflammatory Pathways. Lung. 2018 04; 196(2):219-229.
-
Could calcium channel blockers treat 2 illnesses with 1 pill? Ann Allergy Asthma Immunol. 2017 12; 119(6):473-474.
-
Un-diagnosing persistent adult asthma. Eur Respir J. 2017 11; 50(5).
-
The TLR4-TRIF pathway can protect against the development of experimental allergic asthma. Immunology. 2017 09; 152(1):138-149.